Avi Schroeder is a tenured Associate Professor of Chemical Engineering at the Technion – Israel Institute of Technology, where he heads the Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies. Dr. Schroeder conducted his Postdoctoral studies at the Massachusetts Institute of Technology, and his PhD jointly at the Hebrew and Ben Gurion Universities. Avi is the recipient of more than 30 national and international awards, including named a KAVLI Fellow, the Intel Nanotechnology-, TEVA Pharmaceuticals-, and the Wolf Foundation Krill Awards.
Prof. Schroeder’s Schroeder is an expert in the design, characterization, and clinical implementation of liposomes, his focus is on the development of targeted and personalized medicines, including nanotechnology. Of particular focus to him is using such medicines to better and more effectively treat cancer and improve patients’ quality of life.
Avi is the author of above 50-research papers inventor of 19 patents and co-founder of multiple Technion spin-out startup companies based on these discoveries.
Schroeder is a member of Israel Young National Academy of Sciences, President of the Israel Institute of Chemical Engineers, and an appointed member of the Israel National Council for Civilian Research and Development.
